img

Global Pemetrexed Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pemetrexed Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pemetrexed (brand name Alimta) is a chemotherapy drug manufactured and marketed by Eli Lilly and Company. Its indications are the treatment of pleural mesothelioma and non-small cell lung cancer.
Pemetrexed Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pemetrexed Drug market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pleural mesothelioma and Non-small cell lung cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pemetrexed Drug industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pemetrexed Drug key manufacturers include Eli Lilly and Company, Pfizer, Teva, Eagle Pharmaceuticals, APOTEX, Qilu Pharmaceutical and Biocon, etc. Eli Lilly and Company, Pfizer, Teva are top 3 players and held % sales share in total in 2022.
Pemetrexed Drug can be divided into 100 mg lyophilized powder/vial and 500 mg lyophilized powder/vial, etc. 100 mg lyophilized powder/vial is the mainstream product in the market, accounting for % sales share globally in 2022.
Pemetrexed Drug is widely used in various fields, such as Pleural mesothelioma and Non-small cell lung cancer, etc. Pleural mesothelioma provides greatest supports to the Pemetrexed Drug industry development. In 2022, global % sales of Pemetrexed Drug went into Pleural mesothelioma filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pemetrexed Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Eli Lilly and Company
Pfizer
Teva
Eagle Pharmaceuticals
APOTEX
Qilu Pharmaceutical
Biocon
Segment by Type
100 mg lyophilized powder/vial
500 mg lyophilized powder/vial

Segment by Application


Pleural mesothelioma
Non-small cell lung cancer

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pemetrexed Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pemetrexed Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pemetrexed Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pemetrexed Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pemetrexed Drug introduction, etc. Pemetrexed Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pemetrexed Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Pemetrexed Drug Market Overview
1.1 Pemetrexed Drug Product Overview
1.2 Pemetrexed Drug Market Segment by Type
1.2.1 100 mg lyophilized powder/vial
1.2.2 500 mg lyophilized powder/vial
1.3 Global Pemetrexed Drug Market Size by Type
1.3.1 Global Pemetrexed Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Pemetrexed Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pemetrexed Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pemetrexed Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pemetrexed Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pemetrexed Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pemetrexed Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pemetrexed Drug Sales Breakdown by Type (2018-2024)
2 Global Pemetrexed Drug Market Competition by Company
2.1 Global Top Players by Pemetrexed Drug Sales (2018-2024)
2.2 Global Top Players by Pemetrexed Drug Revenue (2018-2024)
2.3 Global Top Players by Pemetrexed Drug Price (2018-2024)
2.4 Global Top Manufacturers Pemetrexed Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pemetrexed Drug Market Competitive Situation and Trends
2.5.1 Pemetrexed Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pemetrexed Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pemetrexed Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Pemetrexed Drug Market
2.8 Key Manufacturers Pemetrexed Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pemetrexed Drug Status and Outlook by Region
3.1 Global Pemetrexed Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Pemetrexed Drug Historic Market Size by Region
3.2.1 Global Pemetrexed Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Pemetrexed Drug Sales in Value by Region (2018-2024)
3.2.3 Global Pemetrexed Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pemetrexed Drug Forecasted Market Size by Region
3.3.1 Global Pemetrexed Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Pemetrexed Drug Sales in Value by Region (2024-2034)
3.3.3 Global Pemetrexed Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pemetrexed Drug by Application
4.1 Pemetrexed Drug Market Segment by Application
4.1.1 Pleural mesothelioma
4.1.2 Non-small cell lung cancer
4.2 Global Pemetrexed Drug Market Size by Application
4.2.1 Global Pemetrexed Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Pemetrexed Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pemetrexed Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pemetrexed Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pemetrexed Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pemetrexed Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pemetrexed Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pemetrexed Drug Sales Breakdown by Application (2018-2024)
5 North America Pemetrexed Drug by Country
5.1 North America Pemetrexed Drug Historic Market Size by Country
5.1.1 North America Pemetrexed Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Pemetrexed Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Pemetrexed Drug Sales in Value by Country (2018-2024)
5.2 North America Pemetrexed Drug Forecasted Market Size by Country
5.2.1 North America Pemetrexed Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Pemetrexed Drug Sales in Value by Country (2024-2034)
6 Europe Pemetrexed Drug by Country
6.1 Europe Pemetrexed Drug Historic Market Size by Country
6.1.1 Europe Pemetrexed Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Pemetrexed Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Pemetrexed Drug Sales in Value by Country (2018-2024)
6.2 Europe Pemetrexed Drug Forecasted Market Size by Country
6.2.1 Europe Pemetrexed Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Pemetrexed Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Pemetrexed Drug by Region
7.1 Asia-Pacific Pemetrexed Drug Historic Market Size by Region
7.1.1 Asia-Pacific Pemetrexed Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Pemetrexed Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pemetrexed Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pemetrexed Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Pemetrexed Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pemetrexed Drug Sales in Value by Region (2024-2034)
8 Latin America Pemetrexed Drug by Country
8.1 Latin America Pemetrexed Drug Historic Market Size by Country
8.1.1 Latin America Pemetrexed Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Pemetrexed Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pemetrexed Drug Sales in Value by Country (2018-2024)
8.2 Latin America Pemetrexed Drug Forecasted Market Size by Country
8.2.1 Latin America Pemetrexed Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pemetrexed Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Pemetrexed Drug by Country
9.1 Middle East and Africa Pemetrexed Drug Historic Market Size by Country
9.1.1 Middle East and Africa Pemetrexed Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Pemetrexed Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pemetrexed Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pemetrexed Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Pemetrexed Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pemetrexed Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Eli Lilly and Company
10.1.1 Eli Lilly and Company Company Information
10.1.2 Eli Lilly and Company Introduction and Business Overview
10.1.3 Eli Lilly and Company Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Eli Lilly and Company Pemetrexed Drug Products Offered
10.1.5 Eli Lilly and Company Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Pemetrexed Drug Products Offered
10.2.5 Pfizer Recent Development
10.3 Teva
10.3.1 Teva Company Information
10.3.2 Teva Introduction and Business Overview
10.3.3 Teva Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Teva Pemetrexed Drug Products Offered
10.3.5 Teva Recent Development
10.4 Eagle Pharmaceuticals
10.4.1 Eagle Pharmaceuticals Company Information
10.4.2 Eagle Pharmaceuticals Introduction and Business Overview
10.4.3 Eagle Pharmaceuticals Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Eagle Pharmaceuticals Pemetrexed Drug Products Offered
10.4.5 Eagle Pharmaceuticals Recent Development
10.5 APOTEX
10.5.1 APOTEX Company Information
10.5.2 APOTEX Introduction and Business Overview
10.5.3 APOTEX Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 APOTEX Pemetrexed Drug Products Offered
10.5.5 APOTEX Recent Development
10.6 Qilu Pharmaceutical
10.6.1 Qilu Pharmaceutical Company Information
10.6.2 Qilu Pharmaceutical Introduction and Business Overview
10.6.3 Qilu Pharmaceutical Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Qilu Pharmaceutical Pemetrexed Drug Products Offered
10.6.5 Qilu Pharmaceutical Recent Development
10.7 Biocon
10.7.1 Biocon Company Information
10.7.2 Biocon Introduction and Business Overview
10.7.3 Biocon Pemetrexed Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Biocon Pemetrexed Drug Products Offered
10.7.5 Biocon Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pemetrexed Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pemetrexed Drug Industrial Chain Analysis
11.4 Pemetrexed Drug Market Dynamics
11.4.1 Pemetrexed Drug Industry Trends
11.4.2 Pemetrexed Drug Market Drivers
11.4.3 Pemetrexed Drug Market Challenges
11.4.4 Pemetrexed Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pemetrexed Drug Distributors
12.3 Pemetrexed Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 100 mg lyophilized powder/vial
Table 2. Major Company of 500 mg lyophilized powder/vial
Table 3. Global Pemetrexed Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Pemetrexed Drug Sales by Type (2018-2024) & (K Units)
Table 5. Global Pemetrexed Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Pemetrexed Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Pemetrexed Drug Market Share in Value by Type (2018-2024)
Table 8. Global Pemetrexed Drug Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Pemetrexed Drug Sales by Type (2024-2034) & (K Units)
Table 10. Global Pemetrexed Drug Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Pemetrexed Drug Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Pemetrexed Drug Sales Market Share in Value by Type (2024-2034)
Table 13. Global Pemetrexed Drug Price by Type (2024-2034) & (USD/Unit)
Table 14. North America Pemetrexed Drug Sales by Type (2018-2024) & (K Units)
Table 15. North America Pemetrexed Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Pemetrexed Drug Sales (K Units) by Type (2018-2024)
Table 17. Europe Pemetrexed Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Pemetrexed Drug Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Pemetrexed Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Pemetrexed Drug Sales (K Units) by Type (2018-2024)
Table 21. Latin America Pemetrexed Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Pemetrexed Drug Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Pemetrexed Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Pemetrexed Drug Sales by Company (2018-2024) & (K Units)
Table 25. Global Pemetrexed Drug Sales Share by Company (2018-2024)
Table 26. Global Pemetrexed Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Pemetrexed Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Pemetrexed Drug Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Pemetrexed Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Pemetrexed Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pemetrexed Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Pemetrexed Drug Market
Table 33. Key Manufacturers Pemetrexed Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Pemetrexed Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Pemetrexed Drug Sales by Region (2018-2024) & (K Units)
Table 37. Global Pemetrexed Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Pemetrexed Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Pemetrexed Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Pemetrexed Drug Sales by Region (2024-2034) & (K Units)
Table 42. Global Pemetrexed Drug Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Pemetrexed Drug Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Pemetrexed Drug Sales Market Share in Value by Region (2024-2034)
Table 45. Global Pemetrexed Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 46. Global Pemetrexed Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Pemetrexed Drug Sales by Application (2018-2024) & (K Units)
Table 48. Global Pemetrexed Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Pemetrexed Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Pemetrexed Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Pemetrexed Drug Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Pemetrexed Drug Sales by Application (2024-2034) & (K Units)
Table 53. Global Pemetrexed Drug Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Pemetrexed Drug Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Pemetrexed Drug Sales Market Share in Value by Application (2024-2034)
Table 56. Global Pemetrexed Drug Price by Application (2024-2034) & (USD/Unit)
Table 57. North America Pemetrexed Drug Sales by Application (2018-2024) (K Units)
Table 58. North America Pemetrexed Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Pemetrexed Drug Sales by Application (2018-2024) (K Units)
Table 60. Europe Pemetrexed Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Pemetrexed Drug Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Pemetrexed Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Pemetrexed Drug Sales by Application (2018-2024) (K Units)
Table 64. Latin America Pemetrexed Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Pemetrexed Drug Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Pemetrexed Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Pemetrexed Drug Sales by Country (2018-2024) & (K Units)
Table 68. North America Pemetrexed Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Pemetrexed Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Pemetrexed Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Pemetrexed Drug Sales by Country (2024-2034) & (K Units)
Table 72. North America Pemetrexed Drug Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Pemetrexed Drug Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Pemetrexed Drug Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Pemetrexed Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Pemetrexed Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Pemetrexed Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Pemetrexed Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Pemetrexed Drug Sales by Country (2024-2034) & (K Units)
Table 80. Europe Pemetrexed Drug Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Pemetrexed Drug Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Pemetrexed Drug Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Pemetrexed Drug Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Pemetrexed Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Pemetrexed Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Pemetrexed Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Pemetrexed Drug Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Pemetrexed Drug Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Pemetrexed Drug Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Pemetrexed Drug Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Pemetrexed Drug Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Pemetrexed Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Pemetrexed Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Pemetrexed Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Pemetrexed Drug Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Pemetrexed Drug Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Pemetrexed Drug Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Pemetrexed Drug Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Pemetrexed Drug Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Pemetrexed Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Pemetrexed Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Pemetrexed Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Pemetrexed Drug Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Pemetrexed Drug Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Pemetrexed Drug Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Pemetrexed Drug Sales Market Share in Value by Country (2024-2034)
Table 107. Eli Lilly and Company Company Information
Table 108. Eli Lilly and Company Introduction and Business Overview
Table 109. Eli Lilly and Company Pemetrexed Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Eli Lilly and Company Pemetrexed Drug Product
Table 111. Eli Lilly and Company Recent Development
Table 112. Pfizer Company Information
Table 113. Pfizer Introduction and Business Overview
Table 114. Pfizer Pemetrexed Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Pfizer Pemetrexed Drug Product
Table 116. Pfizer Recent Development
Table 117. Teva Company Information
Table 118. Teva Introduction and Business Overview
Table 119. Teva Pemetrexed Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Teva Pemetrexed Drug Product
Table 121. Teva Recent Development
Table 122. Eagle Pharmaceuticals Company Information
Table 123. Eagle Pharmaceuticals Introduction and Business Overview
Table 124. Eagle Pharmaceuticals Pemetrexed Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Eagle Pharmaceuticals Pemetrexed Drug Product
Table 126. Eagle Pharmaceuticals Recent Development
Table 127. APOTEX Company Information
Table 128. APOTEX Introduction and Business Overview
Table 129. APOTEX Pemetrexed Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. APOTEX Pemetrexed Drug Product
Table 131. APOTEX Recent Development
Table 132. Qilu Pharmaceutical Company Information
Table 133. Qilu Pharmaceutical Introduction and Business Overview
Table 134. Qilu Pharmaceutical Pemetrexed Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Qilu Pharmaceutical Pemetrexed Drug Product
Table 136. Qilu Pharmaceutical Recent Development
Table 137. Biocon Company Information
Table 138. Biocon Introduction and Business Overview
Table 139. Biocon Pemetrexed Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Biocon Pemetrexed Drug Product
Table 141. Biocon Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Pemetrexed Drug Market Trends
Table 145. Pemetrexed Drug Market Drivers
Table 146. Pemetrexed Drug Market Challenges
Table 147. Pemetrexed Drug Market Restraints
Table 148. Pemetrexed Drug Distributors List
Table 149. Pemetrexed Drug Downstream Customers
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Pemetrexed Drug Product Picture
Figure 2. Global Pemetrexed Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pemetrexed Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Pemetrexed Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of 100 mg lyophilized powder/vial
Figure 6. Global 100 mg lyophilized powder/vial Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of 500 mg lyophilized powder/vial
Figure 8. Global 500 mg lyophilized powder/vial Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Pemetrexed Drug Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Pemetrexed Drug Sales Market Share by Type in 2022 & 2034
Figure 11. North America Pemetrexed Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Pemetrexed Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Pemetrexed Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Pemetrexed Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Pemetrexed Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Pemetrexed Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Pemetrexed Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Pemetrexed Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Pemetrexed Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Pemetrexed Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Pemetrexed Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Pemetrexed Drug Revenue in 2022
Figure 23. Pemetrexed Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Pleural mesothelioma
Figure 25. Global Pleural mesothelioma Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Non-small cell lung cancer
Figure 27. Global Non-small cell lung cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Global Pemetrexed Drug Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Pemetrexed Drug Sales Market Share by Application in 2022 & 2034
Figure 30. North America Pemetrexed Drug Sales Market Share in Volume by Application in 2022
Figure 31. North America Pemetrexed Drug Sales Market Share in Value by Application in 2022
Figure 32. Europe Pemetrexed Drug Sales Market Share in Volume by Application in 2022
Figure 33. Europe Pemetrexed Drug Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Pemetrexed Drug Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Pemetrexed Drug Sales Market Share in Value by Application in 2022
Figure 36. Latin America Pemetrexed Drug Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Pemetrexed Drug Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Pemetrexed Drug Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Pemetrexed Drug Manufacturing Cost Structure
Figure 41. Pemetrexed Drug Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries